The Role of Antibodies (Ig) and the Respiratory Epithelium in the Prevention of Invasive Meningococcal Infections in Different Age Groups

Project Information

EpIg Men

Grant agreement ID: 835433

DOI

10.3030/835433

Project closed

EC signature date 27 March 2019

Start date 1 July 2019

End date 2 May 2022

Funded under

• EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions

Total cost

€ 187 572,48

EU contribution

€ 187 572,48

Coordinated by

RIJKSINSTITUUT VOOR VOLKSGEZONDHEID EN MILIEU
Netherlands

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Publications

Non-peer reviewed articles (1)

Meningococcal vaccination in adolescents and adults induces bactericidal activity against hyperinvasive complement-resistant meningococcal isolates

Author(s): Milou Ohm, Janine J. Wolf, Debbie M. van Rooijen, Linda Visser, Willem R. Miellet, Rob Mariman, Krzysztof Trzciński, Anne-Marie Buisman, Fiona R.M. van der Klis, Guy A.M. Berbers, Mirjam J. Knol, Nina M. van Sorge, Gerco den Hartog
Published in: medRxiv, 2022, ISSN 0000-0000
Publisher: Cold Spring Harbor Laboratory (CSHL), Yale University, and BMJ
DOI: 10.1101/2022.05.20.22275303